Direct Acting Antivirals (DAAs) to Treat HCV
NS3-4A Protease Inhibitors ("-previr") | NS5A Inhibitors ("-asvir") | NS5B Inhibitors ("-buvir") |
|---|---|---|
Glecaprevir | Ledipasvir | SofosbuvirSofosbuvir |
Grazoprevir | Pibrentasvir | |
Voxilaprevir | Velpatasvir | |
Elbasvir |
In these topics